Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
Virtual reality vendors XRHealth (software) and HTC Vive (hardware) introduce glasses-based system for distracting patients undergoing MRI exams and other anxiety-provoking medical procedures (Oct. 19).
The academics turn the tables in median starting salaries, edging out private-practice interventional radiologists $380,000 to $374,000 while also working fewer weekly call days.
At scientific journals focused on medical imaging, 82% of editors-in-chief and 30% of editorial board members receive financial compensation for these side jobs.
The FDA has approved a CT guidance system for interventional radiologists performing percutaneous procedures with robotics. And the European Union has greenlit a family of mobile CT scanners.
A telehealth practice active in all 50 states has hired a similarly sprawling behavioral-health consultancy to provide physicians with pro-wellbeing, anti-burnout counseling and related services.